Target intelligence / Profile preview

Microtubule-associated protein tau (MAPT) microtubule-binding region HVPGG motif (Tau MTBR HVPGG)

Target
Tau MTBR HVPGG
Molecular classification
Microtubule-associated protein, Intrinsically disordered protein, Cytoskeletal protein
01

Overview

The microtubule-associated protein tau (MAPT) is a critical component of the neuronal cytoskeleton, primarily responsible for stabilizing microtubules in axons (UniProt: P10636). The microtubule-binding region (MTBR) of tau contains three or four highly conserved repeats, each ending with a characteristic HVPGG motif or its variants. This motif plays a dual role: it facilitates the binding of tau to microtubules under physiological conditions and serves as a nucleation site for the formation of pathological tau aggregates in neurodegenerative diseases (von Bergen et al., 2000). In tauopathies such as Alzheimer's disease, the HVPGG motif undergoes conformational changes that promote the assembly of tau into paired helical filaments (PHFs) and neurofibrillary tangles (Wischik et al., 2014). Therapeutic strategies targeting this motif aim to inhibit the aggregation process or promote the disassembly of existing aggregates. Small molecules like hydromethylthionine mesylate (LMTM) have been designed to interact with the MTBR to prevent the pathological transition of tau (Gerson et al., 2014). Understanding the structural dynamics of the HVPGG motif is essential for developing effective disease-modifying treatments for tau-mediated neurodegeneration.

Other names
Tau repeat domain motifTau PGG motifTau microtubule-binding domain motifTau MTBD motifTau MTBR repeat motif
02

Mechanism of action

Inhibition of tau-tau interaction and dissolution of paired helical filaments (PHFs) by binding to the repeat domain and preventing beta-sheet formation.

03

Biological functions

Microtubule stabilizationRegulation of axonal transportCytoskeleton organizationMicrotubule assembly
04

Disease associations

Alzheimer's diseaseFrontotemporal dementiaProgressive supranuclear palsyCorticobasal degenerationPick's diseaseTauopathy
05

Safety considerations

Potential disruption of physiological tau-microtubule bindingImpairment of axonal transportOff-target effects on other microtubule-associated proteinsMethemoglobinemia (associated with high doses of methylene blue derivatives)
06

Interacting drugs

Hydromethylthionine mesylate (LMTM)

3 more in the full profile.

07

Biomarkers

CSF total tauCSF phospho-tau (p-tau181, p-tau217)Tau-PET imaging (e.g., Flortaucipir)Plasma p-tau217

Beyond the preview

Go deeper on Microtubule-associated protein tau (MAPT) microtubule-binding region HVPGG motif (Tau MTBR HVPGG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule-associated protein tau (MAPT) microtubule-binding region HVPGG motif (Tau MTBR HVPGG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call